Updated Jul 16, 2026
Moran Kevin Patrick is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $351K.

Kevin Patrick Moran is an executive associated with Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs. He has been involved in various capacities within the pharmaceutical industry, contributing to the development of therapeutic solutions.
| Role | Insider |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-04 | VNDA | Vanda Pharmaceuticals Inc. | S — Open-market sale | 42.4K | $8.27 | $351K |
| 2026-02-19 | VNDA | Vanda Pharmaceuticals Inc. | A — Grant or award | 125.0K | $0.00 |
Kevin Patrick Moran is an executive associated with Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs. He has been involved in various capacities within the pharmaceutical industry, contributing to the development of therapeutic solutions.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($351K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Moran Kevin Patrick profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.